- Home
- CAC vs ARCT Comparison
CAC vs ARCT Comparison
Compare CAC & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- ARCT
- Stock Information
- Founded
- CAC 1875
- ARCT 2013
- Country
- CAC United States
- ARCT United States
- Employees
- CAC N/A
- ARCT N/A
- Industry
- CAC Major Banks
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- ARCT Health Care
- Exchange
- CAC Nasdaq
- ARCT Nasdaq
- Market Cap
- CAC N/A
- ARCT 487.0M
- IPO Year
- CAC 1997
- ARCT N/A
- Fundamental
- Price
- CAC $45.61
- ARCT $16.90
- Analyst Decision
- CAC Hold
- ARCT Strong Buy
- Analyst Count
- CAC 3
- ARCT 8
- Target Price
- CAC $48.33
- ARCT $61.00
- AVG Volume (30 Days)
- CAC 87.0K
- ARCT 405.9K
- Earning Date
- CAC 01-28-2025
- ARCT 03-06-2025
- Dividend Yield
- CAC 3.74%
- ARCT N/A
- EPS Growth
- CAC 21.89
- ARCT N/A
- EPS
- CAC 3.62
- ARCT N/A
- Revenue
- CAC $177,396,000.00
- ARCT $160,399,000.00
- Revenue This Year
- CAC N/A
- ARCT $7.33
- Revenue Next Year
- CAC $10.12
- ARCT $4.71
- P/E Ratio
- CAC $12.27
- ARCT N/A
- Revenue Growth
- CAC 10.05
- ARCT N/A
- 52 Week Low
- CAC $28.62
- ARCT $14.30
- 52 Week High
- CAC $50.07
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CAC 59.96
- ARCT 45.85
- Support Level
- CAC $43.76
- ARCT $15.34
- Resistance Level
- CAC $46.49
- ARCT $17.95
- Average True Range (ATR)
- CAC 1.18
- ARCT 1.17
- MACD
- CAC 0.24
- ARCT -0.08
- Stochastic Oscillator
- CAC 81.18
- ARCT 39.08
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.